Epidemiological Study in Subjects With Vulvovaginal Candidiases
Completed
- Conditions
- Vulvovaginal Candidiases
- Registration Number
- NCT03064789
- Lead Sponsor
- Dr. Santiago Palacios
- Brief Summary
Epidemiological study about the clinical and microbiological progress in subjects under treatment for a severe vulvovaginal candidiases episody
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 43
Inclusion Criteria
- Sexually active women between 18 and 50 years of age at time of screening
- With diagnosis and symptomatology of VVC
Exclusion Criteria
- Pregnant women
- Diabetes Mellitus
- Women witihin three months after a delivery or misbirth
- Women with vaginal or genital infection symptomatology other than candidiases that needs antibiotic treatment
- Vaginal probiotics use within last three months
- Undiagnosed abnormal genital hemorrhage
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Estimate cure rate in women with severe vuvovaginal candidiases infection At 3 months Women must require antimicotic treatment plus vaginal probiotic following the habitual therapeutic standards
- Secondary Outcome Measures
Name Time Method Evaluate the effectiveness of probiotic treatment by patient. A satisfaction questionnaire will be performed At 3 months The subject will be asked how long the symptoms lasted and the gravity of them
Estimate recurrences At 12 months It will be consider recurrences an asymptomatic period for 7-10 days and a negative culture
Evaluate the link between symptomatology and negative culture At 3 months Evaluate the effectiveness of probiotic treatment by physician At 3 months A gynecological exploration will be performed
Trial Locations
- Locations (1)
Instituto Palacios
🇪🇸Madrid, Spain